Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03627013Phase 3Recruiting
A Phase 3 trial of histidine-tryptophan-ketoglutarate solution (modified) in kidney failure (ESRD), liver failure, sponsored by Franz Köhler Chemie. Started May 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03627013.